Related Experiment Video
Updated: Jun 10, 2025

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.0K
Machine learning-based risk prediction model for medication administration errors in neonatal intensive care units: A
Josephine Henry Basil1, Wern Han Lim2, Sharifah M Syed Ahmad3
1Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Digital Health
|October 21, 2024
Summary
Medication administration errors (MAEs) in neonates pose significant risks. This study developed a machine learning model, AdaBoost, to predict MAEs, identifying intravenous route, working hours, and nursing experience as key factors for intervention.
Area of Science:
- Medical Informatics
- Neonatal Medicine
- Machine Learning in Healthcare
Background:
- Neonates are highly vulnerable to medication administration errors (MAEs) due to physiological immaturity and complex dosing.
- MAEs in neonates can lead to severe harm and significant healthcare costs.
- Developing predictive models for MAEs is critical for patient safety and healthcare efficiency.
Purpose of the Study:
- To develop and validate a machine learning (ML) model for predicting MAEs in neonatal intensive care units (NICUs).
- To identify key risk factors associated with MAEs in neonates.
- To provide a tool for timely interventions to reduce MAE occurrence.
Main Methods:
- A prospective, direct observational study in five Malaysian NICUs.
- Direct observation of nurses during medication preparation and administration for 1093 doses.
- Application of ten ML algorithms, with AdaBoost selected as the best performer based on F1-score.
Main Results:
- The AdaBoost model achieved an F1-score of 83.28%, accuracy of 77.63%, and an area under the ROC curve of 82.95%.
- Key predictors for MAEs included the intravenous route of administration, nurse working hours, and nursing experience.
- The study successfully identified influential features for MAE prediction in neonates.
Conclusions:
- An ML-based model, specifically AdaBoost, was successfully developed and validated for predicting MAEs in neonates.
- The model can assist healthcare providers in identifying high-risk situations and implementing timely interventions.
- This predictive approach holds potential for reducing harm and improving safety in neonatal medication administration.

